Glacier Bay Receives $10,000,000 Series C Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1e9a1b3f-2e4e-46d7-aa85-6bcfb140f90c&Preview=1 Date 9/3/2009 Company Name Glacier Bay Mailing Address 2930 Faber Street Union City, CA 94587 Company Description Glacier Bay is an internationally recognized leader in advanced thermal control, sound reduction, and DC power management technologies. Website http://www.glacierbay.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Series C Proceeds Purposes Now … Continue reading “Glacier Bay Receives $10,000,000 Series C Funding”

MITX Marketing Technology Series—Get Relevant: The Next Generation of Website Personalization

Info and registration here. Cost: $35 members; $70 non-members Description: Marketers have been told for years the web can support highly personalized experiences. However very few websites today are actually leveraging this targeted content. This is quickly changing. A new breed of technology is putting marketers in charge of creating more relevant experiences. Experiences that … Continue reading “MITX Marketing Technology Series—Get Relevant: The Next Generation of Website Personalization”

Science & Technology Discovery Series (Technology Alliance)

Info and registration here. Speaker: Dr. Tadayoshi Kohno Tadayoshi Kohno is a computer security expert and an Assistant Professor of Computer Science & Engineering at the University of Washington. As a grad student, Dr. Kohno made a name for himself when he presented his research on security flaws in Diebold voting machines to the U.S. … Continue reading “Science & Technology Discovery Series (Technology Alliance)”

Intel Capital’s Jeff Schrock on Trends in Video, Connected Consumers, and E-Commerce

What’s it like in the world of corporate venture capital these days? For Jeff Schrock, it’s pretty stable and good. Probably more stable than at many boutique venture firms, which are under increased pressure to raise funds and get quick returns. Schrock is a Seattle-based tech investor with Intel Capital. In a previous life, he … Continue reading “Intel Capital’s Jeff Schrock on Trends in Video, Connected Consumers, and E-Commerce”

Gloucester Wins Recommendation from FDA Panel for Lymphoma Drug

Gloucester Pharmaceuticals likely made its venture capitalists some fast money today. The Cambridge, MA-based biotech company—which scored $29 million in venture capital last week—won an unambiguous vote of confidence today from an FDA advisory panel for its drug for a rare form of lymphoma. Gloucester’s drug for cutaneous T-cell lymphoma, romidepsin, was recommended by the … Continue reading “Gloucester Wins Recommendation from FDA Panel for Lymphoma Drug”

Calling All Startups: nPost Rolls Out Metrics Program to Analyze Tech Industry Trends

Wondering how your startup stacks up with others in your sector? Or how consumer Internet companies, say, compare with mobile startups? Seattle-based nPost, a media and resource site for tech entrepreneurs, is preparing to launch a quarterly report on startups—that are based not just in Seattle, but everywhere—to help answer such questions. The program, called … Continue reading “Calling All Startups: nPost Rolls Out Metrics Program to Analyze Tech Industry Trends”

MabVax Raising $4 Million

MabVax Therapeutics, a San Diego biotech developing novel vaccines and human antibodies for the treatment of cancer, plans to raise $4 million from investors, according to a recent filing with the Securities and Exchange Commission. The company, which has raised about $500,000 so far, was founded in 2006 to develop polyvalent versions of existing monovalent … Continue reading “MabVax Raising $4 Million”

As Startup Considers IPO, Mission Ventures’ Leo Spiegel Sees End to San Diego’s VC Lockdown

Leo Spiegel says he’s sensing a change in San Diego’s listless venture capital sector. Spiegel quickly adds that he doesn’t have the data to back it up. It’s just a feeling he has, a sailor’s instinct for a freshening breeze in the horse latitudes. Yet as a managing partner at San Diego’s Mission Ventures, Spiegel’s … Continue reading “As Startup Considers IPO, Mission Ventures’ Leo Spiegel Sees End to San Diego’s VC Lockdown”

Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News

New England’s life sciences startups gave us a lot to write about last week. —Luke talked with Genocea Biosciences CEO Staph Bakali about his Cambridge, MA-based startup’s strategy for developing new vaccines. The approach, based on research at Harvard Medical School, helped Genocea garner $23 million in venture capital earlier this year and has drawn … Continue reading “Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News”

Dimdim Takes on the Webinar Big Boys

Though it may be one of the most grating neologisms of the Internet era, the “webinar” has grown into an important, often profitable, way for group leaders to reach employees and/or followers and for companies to reach existing and potential customers. The leading providers of webinar hosting technology are the WebEx division of Cisco Systems … Continue reading “Dimdim Takes on the Webinar Big Boys”

Life Technologies to Get $450M for Business Stake

Carlsbad, CA-based Life Technologies (NASDAQ:[[ticker:LIFE]]) said today that it plans to sell its stake in its mass spectrometry business to Danaher (NYSE:[[ticker:DHR]]) for $450 million in cash. Danaher, based in Washington, D.C., has also agreed to buy the company with which Life Technologies jointly owns the business, MDS Analytical Technologies, headquartered in Ontario, Canada. Life … Continue reading “Life Technologies to Get $450M for Business Stake”

Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug

[See update at 3:35 pm Eastern with FDA panel vote in favor.] You can bet that the people who just put $29 million into Gloucester Pharmaceuticals a few days ago will be watching very closely today for signs they got their money’s worth. The Cambridge, MA-based biotech company will try to make its case today … Continue reading “Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug”

The Rosetta Diaspora: Genetics Talent Stays Close to Home After Merck Shuts Down in Seattle

Merck was the only Big Pharma company with a toehold in Seattle a year ago, so when it decided to shut down its Rosetta Inpharmatics research center last October as part of global cost-cutting, some local biotechies moaned about how this was another sign of the apocalypse for a once-thriving life sciences scene. But after … Continue reading “The Rosetta Diaspora: Genetics Talent Stays Close to Home After Merck Shuts Down in Seattle”

Dashwire Raises $1.1M More

Seattle-based Dashwire, which makes mobile-Web synchronization software, has raised about $1.1 million in new equity funding, according to founder and CEO Ford Davidson, who confirmed information from an SEC filing. Bellevue-based Trilogy Equity Partners is a new investor, with co-founder and partner Mikal Thomsen listed as a director. Back in May, Dashwire raised $1.6 million … Continue reading “Dashwire Raises $1.1M More”

Orexigen Aims to Redefine Obesity, as Amgen Vet Revamps Company to Compete

San Diego’s Orexigen Therapeutics looked like just another biotech on the verge of collapse at the beginning of the year. Its CEO was diagnosed with a terminal case of leukemia and soon died. Three other senior executives had just quit. The company halted development of two experimental drugs to conserve cash. Orexigen (NASDAQ: [[ticker:OREX]]) sought … Continue reading “Orexigen Aims to Redefine Obesity, as Amgen Vet Revamps Company to Compete”

40 Years After Sparking the Internet, BBN’s Long Search for a Home Ends…At Home

If you had to pick a birthday for the Internet, September 2, 1969—40 years ago today—would be a good candidate. That’s the day a team of researchers at UCLA sent the first computer-to-computer transmissions using the Interface Message Processor (IMP), the grand-daddy of all packet-switching routers and the foundation of the military-university Arpanet, which paved … Continue reading “40 Years After Sparking the Internet, BBN’s Long Search for a Home Ends…At Home”

BrightScope Garners $2,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b89d7aaf-c7c9-4e11-b53b-a95e861353ae&Preview=1 Date 9/2/2009 Company Name BrightScope Mailing Address Undisclosed San Diego, 92121 Company Description BrightScopeTM, Inc. is an independent provider of 401k ratings and financial intelligence to plan sponsors, advisors, and participants in all 50 states. Our mission is to increase the retirement security of America’s workforce by bringing transparency and efficiency … Continue reading “BrightScope Garners $2,000,000 Series B Funding Round”

Vinfolio Secures $4,500,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b0aea7d1-ebfc-4f10-9585-16fe7cc3fafe&Preview=1 Date 9/2/2009 Company Name Vinfolio Mailing Address 1890 Bryant Street San Francisco, CA 94110 Company Description Offers wine and services to wine collectors and enthusiasts. Website http://www.vinfolio.com Transaction Type Venture Equity Transaction Amount $4,500,000 Transaction Round Series A Proceeds Purposes The investment will accelerate the growth of the Vinfolio Marketplace and … Continue reading “Vinfolio Secures $4,500,000 Series A Funding Round”

Athena Feminine Technologies Obtains $2,000,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ba76314e-e21b-4ac2-a097-2d33865b6b87&Preview=1 Date 9/2/2009 Company Name Athena Feminine Technologies Mailing Address 21 Orinda Way C246 Orinda, CA 94563 Company Description Athena Feminine Technologies, Inc. is a company dedicated to improving the quality of life of women worldwide by providing products that address female pelvic and reproductive health concerns. Since many of Athena’s top … Continue reading “Athena Feminine Technologies Obtains $2,000,000 Series A Funding Round”

Advanced Cell Diagnostics Garners $5,400,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a738670b-cafd-4d4d-85ee-3f40b142d20b&Preview=1 Date 9/2/2009 Company Name Advanced Cell Diagnostics Mailing Address 26229 Eden Landing Road Hayward, CA 94545 Company Description Advanced Cell Diagnostics (ACD),a developer of cell- and tissue-based diagnostic tests for personalized medicine. Website http://www.acdbio.com Transaction Type Venture Equity Transaction Amount $5,400,000 Transaction Round Series A Proceeds Purposes ACD said the funding … Continue reading “Advanced Cell Diagnostics Garners $5,400,000 Series A Funding”

Nor1 Secures $8,100,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a7a66f74-82e1-43c5-8891-90d57c6e14e8&Preview=1 Date 9/2/2009 Company Name Nor1 Mailing Address 440 N. Wolfe Road Sunnyvale, CA 94085 Company Description Nor1, Inc. is headquartered in Silicon Valley with European offices in Amsterdam. It serves a variety of industries by assisting them with creating additional revenue and profit by utilizing Nor1’s patented concepts. Website http://www.nor1.com Transaction … Continue reading “Nor1 Secures $8,100,000 New Financing”

SaaSure Garners $750,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6949f88b-17e8-41e2-8ff5-a4cae61089b8&Preview=1 Date 9/2/2009 Company Name SaaSure Mailing Address 400 2nd Street San Francisco, CA 94107 Company Description SaaSure, a stealthy cloud environment provider with its first product launching this fall. Website http://www.saasure.com Transaction Type Venture Equity Transaction Amount $750,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture … Continue reading “SaaSure Garners $750,000 New Round”

Greystripe Secures $2,000,000 Series C Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=75bee053-c112-4a3d-9fc1-ab8ffda2a90b&Preview=1 Date 9/2/2009 Company Name Greystripe Mailing Address 150 Executive Park Blvd. San Francisco, CA 94134 Company Description Greystripe’s AdWRAP mobile in-game advertising network provides a platform for advertisers and publishers to engage mobile audiences of all ages anywhere, anytime, while offering free ad-supported mobile content. Website http://www.greystripe.com Transaction Type Venture Equity … Continue reading “Greystripe Secures $2,000,000 Series C Funding”

DeepDyve Secures $375,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dd234536-3a33-40c4-a793-b158af135abd&Preview=1 Date 9/2/2009 Company Name DeepDyve Mailing Address 111 W. Evelyn Ave Sunnyvale, CA 94086 Company Description DeepDyve, formerly Infovell, delivers the research engine for information-savvy consumers who want access to expert content on topics they care about. For the first time, researchers, students, technical professionals, business users, and other information consumers … Continue reading “DeepDyve Secures $375,000 New Financing Round”

Ooma Lands $18,300,000 Series D Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8e505244-19ef-4b6b-a55b-c52f2adc8eb5&Preview=1 Date 9/2/2009 Company Name Ooma Mailing Address 1840 Embarcadero Rd. Palo Alto, CA 94303 Company Description The company is developing software for the consumer voice applications market. Website http://www.ooma.com Transaction Type Venture Equity Transaction Amount $18,300,000 Transaction Round Series D Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor … Continue reading “Ooma Lands $18,300,000 Series D Round”

BIF-5 Collaborative Innovation Summit

**Special discount for Xconomy readers–see below**–The Business Innovation Factory’s annual innovation summit, now in its 5th year (hence, BIF-5), has emerged as one of the country’s most exciting and inspiring innovation escapes. The event is co-hosted by Xconomy board member Bill Taylor and features 25 personal stories from some of the world’s “most compelling innovators, … Continue reading “BIF-5 Collaborative Innovation Summit”

EMC to Buy Kazeon

Hopkinton, MA-based EMC (NYSE: [[ticker:EMC]]) announced today it has agreed to buy Kazeon Systems, a Mountain View, CA, maker of “eDiscovery” software for litigation support inside large corporations and law firms. EMC said Kazeon will become part of its Content Management and Archiving business unit, and that Kazeon’s technology will complement the company’s existing line … Continue reading “EMC to Buy Kazeon”

DivX Gets Internet TV Technology

San Diego digital media company DivX (NASDAQ: [[ticker:DIVX]]) says it has acquired AnySource Media, a Malvern, PA-based developer of Internet television streaming technology that enables users to connect their TV to Internet-based content and services. The deal could be valued up to $15 million, with $7.5 million paid in cash upfront and another $7.5 million … Continue reading “DivX Gets Internet TV Technology”

Led by Ex-Microsofties, Raveable Makes Sense of User Reviews, Gives Hotel Ratings at a Glance

Raveable is a year-old Seattle-area startup that launched its hotel review summarization website in May. If there were a Raveable entry for Raveable itself, here’s what it might say: Ranked 116 out of 340 tech startup websites in Seattle. The good: Team is ambitious and knowledgeable; large market; useful technology; fun interface; customer focused; strong … Continue reading “Led by Ex-Microsofties, Raveable Makes Sense of User Reviews, Gives Hotel Ratings at a Glance”

Genzyme’s Woes Piling Up as FDA Panel Says Data on Leukemia Drug are Lacking

The bad news just keeps flowing for Genzyme. Today, an FDA advisory panel recommended against approving the company’s application to start marketing a leukemia drug to patients over 60, saying the Cambridge, MA-based biotech giant hadn’t produced enough evidence that the drug is safe and effective for those patients. The agency isn’t required to follow … Continue reading “Genzyme’s Woes Piling Up as FDA Panel Says Data on Leukemia Drug are Lacking”

Acadia Pharma Shares Crash After Lead Parkinson’s Drug Fails in Trial

San Diego-based Acadia Pharmaceuticals stock price collapsed today on news that its drug for psychosis related to Parkinson’s disease failed in a late-stage clinical trial. It’s a big setback for the small firm because it has no products on the market, and the Parkinson’s drug was the candidate furthest along in its development pipeline. The … Continue reading “Acadia Pharma Shares Crash After Lead Parkinson’s Drug Fails in Trial”

Clearwire Does WiMax in Bellingham, Boise

Kirkland, WA-based Clearwire (NASDAQ: [[ticker:CLWR]]) announced today it has rolled out its WiMax wireless broadband service in 10 new cities, including Bellingham, WA, and Boise, ID. Also on the list are eight cities in Texas, including Amarillo, Corpus Christi, Lubbock, and Waco. The new markets join Las Vegas, Atlanta, Baltimore, and Portland, OR as WiMax … Continue reading “Clearwire Does WiMax in Bellingham, Boise”

SeaChange Buys EventIS for $45M

SeaChange International, an Acton, MA-based provider of technology for video-on-demand television, said today that it has acquired its Dutch counterpart EventIS Group in a deal valued at $45 million. The deal also includes additional performance-based payments to EventIS shareholders that depend on certain annual sales goals for SeaChange (NASDAQ:[[ticker:SEAC]]) and EventIS products and services through … Continue reading “SeaChange Buys EventIS for $45M”

Another Genzyme Rival Advancing

The corporate parent of Cambridge, MA-based Shire Human Genetic Therapies said today that it has wrapped up the submission of its FDA application for approval of velaglucerase alfa, an enzyme-replacement therapy for patients with Type 1 Gaucher’s disease. The company still needs FDA approval before it begins U.S. sales of the treatment. Cambridge-based Genzyme (NASDAQ:[[ticker:GENZ]]) … Continue reading “Another Genzyme Rival Advancing”

Raytheon to Acquire BBN

In a convergence of two legendary Boston-area technology concerns, Waltham, MA-based defense contracting giant Raytheon (NYSE: [[ticker:RTN]]) said today it will acquire Cambridge, MA-based BBN Technologies in a deal expected to close by the end of this year. Financial terms weren’t disclosed. BBN pioneered the development of the Arpanet, the predecessor to today’s Internet, and … Continue reading “Raytheon to Acquire BBN”

Healthcare Venture Funding Goes to Medsphere, Aubrey, and Animal Cell Therapies—A Brief Roundup

If new venture rounds are any indication, the life sciences sector is showing renewed signs of life, with several startups raising capital in the San Diego region, according to recent filings with the U.S. Securities and Exchange Commission. Industry watchers are expecting healthcare IT, in particular, to heat up as the federal government’s carrot-and-stick approach … Continue reading “Healthcare Venture Funding Goes to Medsphere, Aubrey, and Animal Cell Therapies—A Brief Roundup”

Omeros Gets Ready for IPO, Cray Buys SiCortex Assets, ClearEdge Raises Cash, & More Seattle-Area Deals News

It was a fairly quiet week for deals in the Northwest, with just a trickle of activity in software, computing, cleantech, and life sciences. But there was a hint that the IPO window may be about to open. —Seattle-based Cray (NASDAQ: [[ticker:CRAY]]), the supercomputing company, acquired some assets from SiCortex, a Maynard, MA-based computing firm … Continue reading “Omeros Gets Ready for IPO, Cray Buys SiCortex Assets, ClearEdge Raises Cash, & More Seattle-Area Deals News”

7 Boston Startup CEOs Boil Their Company Culture Down to One Word

First, let me get this out up front—I’m ripping off the idea for this column from my colleague Greg Huang, editor of Xconomy Seattle. Thanks Greg! Second, I spend a lot of time talking with venture capitalists about the startup business, and with entrepreneurs about venture capitalists AND the startup business. But those can be … Continue reading “7 Boston Startup CEOs Boil Their Company Culture Down to One Word”

AVI Offers Glimmer of Hope for Muscular Dystrophy, Says UW Neuroscientist Jeff Chamberlain

Jeff Chamberlain first heard about muscular dystrophy as a kid watching the annual Jerry Lewis telethon on Labor Day weekend. That TV program has been raising awareness for 43 years about this genetic disorder that breaks down muscles, eventually crippling and killing young boys and men, usually by their 20s. The disease really captured Chamberlain’s … Continue reading “AVI Offers Glimmer of Hope for Muscular Dystrophy, Says UW Neuroscientist Jeff Chamberlain”

Frame Media Reinvents Itself as Thinking Screen, Goes After Larger “Connected Screen” Market

Wireless digital photo frames, considered one of the hot new categories in consumer electronics back in 2006 and 2007, haven’t taken off as quickly as expected. People love digital frames, but they’ve tended to buy them as gifts pre-loaded with photos they uploaded to the Web, meaning many frames still don’t come with their own … Continue reading “Frame Media Reinvents Itself as Thinking Screen, Goes After Larger “Connected Screen” Market”

San Diego’s Palkion Chases Amgen’s Big Market, Joins Race to Develop Oral Anemia Drug

Amgen’s big break came in the 1980s when it learned how to stimulate the body to make more oxygen-carrying red blood cells. Nobody has topped this achievement for the treatment of anemia in the past 20 years. But now San Diego’s Palkion has joined a list of competitors that hope to capture some billions of … Continue reading “San Diego’s Palkion Chases Amgen’s Big Market, Joins Race to Develop Oral Anemia Drug”

New Constellation Pharma CEO Gives Expected Timeline for Epigenetics Firm’s Cancer Drug Research

For all of the publicity it’s gotten lately, Constellation Pharmaceuticals has managed to keep a remarkably tight lid on the specifics of its research. So I was enthused when the Cambridge, MA-based firm’s new CEO, Mark Goldsmith, gave me some insights into where the firm stands in advancing potential drugs in the emerging field of … Continue reading “New Constellation Pharma CEO Gives Expected Timeline for Epigenetics Firm’s Cancer Drug Research”

Fluidigm Receives $10,700,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=650e12ae-f780-471e-921b-4333c9b079d0&Preview=1 Date 9/1/2009 Company Name Fluidigm Mailing Address 7000 Shoreline Court South San Francisco, CA 94080 Company Description Fluidigm is making that vision a reality through the introduction of integrated fluidic circuits (IFCs). Our mission is to develop, manufacture, and distribute systems composed of IFCs, instrumentation, and consumables, enabling new efficiencies in … Continue reading “Fluidigm Receives $10,700,000 New Funding Round”

Faculte Receives $2,700,000 Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=19ccc234-8de1-4907-9665-7020546ac198&Preview=1 Date 9/1/2009 Company Name Faculte Mailing Address 1250 Bayhill Drive San Bruno, CA 94066 Company Description Faculte is a multimedia communications platform for professionals and organizations. The company was founded in 2007 with a simple mission: to help people and businesses use rich media (video, voice, visuals) to share and sell … Continue reading “Faculte Receives $2,700,000 Series A Financing”

Skyfire Obtains $5,000,000 Series C Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ef06f9a3-21d9-4d0f-9db6-90a3fa5e25b8&Preview=1 Date 9/1/2009 Company Name Skyfire Mailing Address 444 Castro Street Mountain View, CA 94041 Company Description Skyfire is an exciting venture-backed innovator in mobile web browsing with a mission to dramatically improve your browsing experience on mobile phones. We created the only mobile browser that delivers both the speed and media-rich … Continue reading “Skyfire Obtains $5,000,000 Series C Financing”